Significant Ownership of Third Rock Ventures IV, L.P.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Third Rock Ventures IV, L.P. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- Boston, MA
- Manager signature
- /s/ Kevin Gillis - Kevin Gillis, COO of TRV GP IV, LLC, the general partner of Third Rock Ventures GP IV, L.P., the general partner of Third Rock Ventures IV, L.P.
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Third Rock Ventures IV, L.P. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Third Rock Ventures IV, L.P.
Significant Ownership of Third Rock Ventures IV, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MAZE | Maze Therapeutics, Inc. | Common Stock, $0.001 par value per share | 9.3% | $179,808,372 | -$64,304,000 | 4,473,958 | -26% | Third Rock Ventures IV, L.P. | 31 Dec 2025 |
| TNGX | Tango Therapeutics, Inc. | Common Stock | 4.7% | $74,901,244 | -$17,625,000 | 6,374,574 | -19% | Third Rock Ventures IV, L.P. | 06 Feb 2026 |
Schedules 13D/G Reported by Third Rock Ventures IV, L.P.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.